浙江诺得药业有限公司
- Country
- Ownership
- -
- Established
- 2018-12-07
- Employees
- -
- Market Cap
- -
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
63
NMPA:63
Drug Approvals
Pravastatin Sodium Tablets
- Product Name
- 普伐他汀钠片
- Approval Number
- 国药准字H20253951
- Approval Date
- Apr 15, 2025
NMPA
Pravastatin Sodium Tablets
- Product Name
- 普伐他汀钠片
- Approval Number
- 国药准字H20253952
- Approval Date
- Apr 15, 2025
NMPA
Ezetimibe and Simvastatin Tablets
- Product Name
- 依折麦布辛伐他汀片
- Approval Number
- 国药准字H20253949
- Approval Date
- Apr 15, 2025
NMPA
Pravastatin Sodium Tablets
- Product Name
- 普伐他汀钠片
- Approval Number
- 国药准字H20253858
- Approval Date
- Apr 8, 2025
NMPA
Edoxaban Tosilate Tablets
- Product Name
- 甲苯磺酸艾多沙班片
- Approval Number
- 国药准字H20253622
- Approval Date
- Mar 11, 2025
NMPA
Edoxaban Tosilate Tablets
- Product Name
- 甲苯磺酸艾多沙班片
- Approval Number
- 国药准字H20253623
- Approval Date
- Mar 11, 2025
NMPA
Avatrombopag Maleate Tablets
- Product Name
- 马来酸阿伐曲泊帕片
- Approval Number
- 国药准字H20253526
- Approval Date
- Mar 4, 2025
NMPA
Edoxaban Tosilate Tablets
- Product Name
- 甲苯磺酸艾多沙班片
- Approval Number
- 国药准字H20253525
- Approval Date
- Mar 4, 2025
NMPA
Dabigatran Etexilate Capsules
- Product Name
- 达比加群酯胶囊
- Approval Number
- 国药准字H20253079
- Approval Date
- Jan 8, 2025
NMPA
Dabigatran Etexilate Capsules
- Product Name
- 达比加群酯胶囊
- Approval Number
- 国药准字H20253080
- Approval Date
- Jan 8, 2025
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
Clinical Trials
No trials found
News
No news found